Journal of Hepatology and Gastrointestinal disorders
Open Access
ISSN: 2475-3181
ISSN: 2475-3181
Roxana M
Carol Davila University of Medicine and Pharmacy, Romania
Keynote: J Hepatol Gastroint Dis
The inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is an inflammatory chronic condition that is relevant for patients, their families and society, through the physical, psychological, familial and social dimensions of life. Both are known to have higher incidence and prevalence in Northern Europe and North America and lower incidence and prevalence in Central and Southern Europe and South America. In Romania, the number of patients with IBD is about 15000. The present communication highlights the impact of IBD on QOL (quality of life), the main question being how much could affect the quality of life of the patients with these disorders? Results showed that IBD significantly affected patients QOL, which indicated the need and importance of using health-related QOL to assess the progression of the disease. The use of IBDQ should be implanted for regular follow up in the clinic to evaluate the response of our management.
Roxana M has completed her PhD in 2009 from University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania. She is Associate Professor at University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania. She participated at many International and National Conferences and Congresses. She has about 100 publications in national and international medical journals. Also, she is attending physician in both Gastroenterology and Medical Assessment and Work Capacity Reabilitation specilities.